Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03116698 · ClinicalTrials.gov registry record · Phase 2
A Study to Evaluate Two Concentrations of DFD-07 Cream, in Subjects With Actinic Keratosis (AK) of the Face and/or Scalp Over a 12-week Treatment Period
A Phase 2 study of Actinic Keratosis (AK), sponsored by Dr. Reddy's Laboratories Limited.
- Completed
- Registry status
- Phase 2
- Development phase
- 240
- Enrollment target
- 20
- Study locations
NCT03116698 is a Phase 2 study of Actinic Keratosis (AK) that has completed, run by Dr. Reddy's Laboratories Limited. The registered enrollment target is 240 participants. The trial reports 20 study locations across 6 states.
The verdict
NCT03116698, a Phase 2 study of Actinic Keratosis (AK), has completed, sponsored by Dr. Reddy's Laboratories Limited.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 240 participants
- Enrollment target
- 20
- Study locations
Study Summary
Once or twice daily 12 week treatment in patients with Actinic Keratosis randomized to treatment in one of four arms.
Conditions Studied
Interventions
- DRUG Low dose DFD07 once daily
- DRUG High dose DFD07 once daily
- DRUG High dose DFD07 twice daily
- DRUG Placebo twice daily
Study Locations (20)
Florida
- Investigator Site 16 - Boca Raton
- Investigator Site 8 - Lake City
- Investigator Site 7 - Miami
- Investigator Site 19 - Miami
- Investigator Site 20 - Miami Lakes
- Investigator Site 17 - Ormond Beach
- Investigator Site 6 - West Palm Beach
Texas
- Investigator Site 10 - Austin
- Investigator Site 4 - Houston
- Investigator Site 5 - Plano
- Investigator Site 11 - San Antonio
- Investigator Site 2 - San Antonio
- Investigator Site 12 - San Antonio
California
- Investigator Site 3 - Cerritos
- Investigator Site 1 - Fremont
- Investigator Site 9 - Palm Springs
- Investigator Site 18 - Santa Ana
New Jersey
- Investigator Site 13 - Verona
New York
- Investigator Site 15 - Stony Brook
Pennsylvania
- Investigator Site 14 - Fort Washington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2017-02-14 |
| Est. Completion | 2018-07-05 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03116698
The ClinicalTrials.gov registry entry for NCT03116698 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 240 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dr. Reddy's Laboratories Limited, which has 52 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Actinic Keratosis (AK) appearing as the primary indexed condition, and to 4 interventions - of which Low dose DFD07 once daily is the first listed.
NCT03116698 reports 20 study locations spanning 6 distinct geographic areas - top geographies include Florida, Texas, California.
Frequently Asked Questions
What is clinical trial NCT03116698 about?
NCT03116698 is a clinical study titled "A Study to Evaluate Two Concentrations of DFD-07 Cream, in Subjects With Actinic Keratosis (AK) of the Face and/or Scalp Over a 12-week Treatment Period". Once or twice daily 12 week treatment in patients with Actinic Keratosis randomized to treatment in one of four arms.
What is the current status of trial NCT03116698?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 240 participants. The study started on 2017-02-14. Estimated completion is 2018-07-05.
What conditions does trial NCT03116698 study?
This clinical trial studies the following conditions: Actinic Keratosis (AK).
What interventions are being tested in trial NCT03116698?
The interventions under investigation include: Low dose DFD07 once daily (DRUG), High dose DFD07 once daily (DRUG), High dose DFD07 twice daily (DRUG), Placebo twice daily (DRUG).
Who is sponsoring clinical trial NCT03116698?
This trial is sponsored by Dr. Reddy's Laboratories Limited, which has 52 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03116698 being conducted?
This trial has 20 study locations across California, Florida, New Jersey, New York, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Actinic Keratosis (AK)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.